EUVIMEDEUVIMED entdecken
Crossref

Analysis of the clinical characteristics and risk factors for dabigatran-induced bleeding in patients with nonvalvular atrial fibrillation

Xiaojuan Wang, Xiaoying Wang, Ya Li, Zhenfeng Yang, Dong Wu

Int. Journal of Clinical Pharmacology and Therapeutics · 01.01.2026 · 64 (01) · 18-27

DOI: 10.5414/cp204807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.01.2026. Verfasst von Xiaojuan Wang und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dabigatran, Atrial Fibrillation, Hemorrhage, Antithrombins.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DabigatranAtrial FibrillationHemorrhageAntithrombinsBlood CoagulationHumansMaleFemaleRetrospective StudiesAgedRisk FactorsMiddle AgedAged, 80 and overTime FactorsRisk Assessment

Substanzen

DabigatranAntithrombins

Zitieren

APA

Wang, X., Wang, X., Li, Y., Yang, Z., & Wu, D. (2026). Analysis of the clinical characteristics and risk factors for dabigatran-induced bleeding in patients with nonvalvular atrial fibrillation. Int. Journal of Clinical Pharmacology and Therapeutics, 64(01), 18-27. https://doi.org/10.5414/cp204807

Vancouver

Wang X, Wang X, Li Y, Yang Z, Wu D. Analysis of the clinical characteristics and risk factors for dabigatran-induced bleeding in patients with nonvalvular atrial fibrillation. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(01):18-27. doi:10.5414/cp204807

BibTeX
@article{Wang2026,
  author = {Wang, Xiaojuan and Wang, Xiaoying and Li, Ya and Yang, Zhenfeng and Wu, Dong},
  title = {Analysis of the clinical characteristics and risk factors for dabigatran-induced bleeding in patients with nonvalvular atrial fibrillation},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2026},
  volume = {64},
  number = {01},
  pages = {18--27},
  doi = {10.5414/cp204807}
}
Kostenlos starten →